Autism Research and Treatment [10] I. Maezawa and L. W. Jin, “Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate,” Journal of Neuroscience, vol. 30, no. 15, pp. 5346–5356, 2010. [11] C. A. Pardo, D. L. Vargas, and A. W. Zimmerman, “Immunity, neuroglia and neuroinﬂammation in autism,” International Review of Psychiatry, vol. 17, no. 6, pp. 485–495, 2005. [12] W. J. Streit, “Microglia as neuroprotective, immunocompetent cells of the CNS,” GLIA, vol. 40, no. 2, pp. 133–139, 2002. [13] D. L. Vargas, C. Nascimbene, C. Krishnan, A. W. Zim- merman, and C. A. Pardo, “Neuroglial activation and neuroinﬂammation in the brain of patients with autism,” Annals of Neurology, vol. 57, no. 1, pp. 67–81, 2005. [14] W. J. Streit, “Microglia and neuroprotection: implications for Alzheimer’s disease,” Brain Research Reviews, vol. 48, no. 2, pp. 234–239, 2005. [15] A. J. Husband, “The immune system and integrated home- ostasis,” Immunology and Cell Biology, vol. 73, no. 4, pp. 377– 382, 1995. [16] L. Vitkovic, J. Bockaert, and C. Jacque, “’Inﬂammatory’ cytokines’ neuromodulators in normal brain?” Journal of Neurochemistry, vol. 74, no. 2, pp. 457–471, 2000. [17] R. Dantzer and K. W. Kelley, “Twenty years of research on cytokine-induced sickness behavior,” Brain, Behavior, and Immunity, vol. 21, no. 2, pp. 153–160, 2007. [18] S. F. Maier and L. R. Watkins, “Cytokines for psychologists: implications of bidirectional immune-to-brain communi- cation for understanding behavior, mood, and cognition,” Psychological Review, vol. 105, no. 1, pp. 83–107, 1998. [19] F. Mignini, V. Streccioni, and F. Amenta, “Autonomic inner- vation of immune organs and neuroimmune modulation,” Autonomic and Autacoid Pharmacology, vol. 23, no. 1, pp. 1– 25, 2003. [20] D. Wrona, “Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems,” Journal of Neuroimmunology, vol. 172, no. 1-2, pp. 38–58, 2006. [21] F. Ginhoux, M. Greter, M. Leboeuf et al., “Fate mapping analysis reveals that adult microglia derive from primitive macrophages,” Science, vol. 330, no. 6005, pp. 841–845, 2010. [22] P. Rezaie and D. Male, “Mesoglia and microglia—a historical review of the concept of mononuclear phagocytes within the central nervous system,” Journal of the History of the Neurosciences, vol. 11, no. 4, pp. 325–374, 2002. [23] D. Giulian, D. G. Young, J. Woodward, D. C. Brown, and L. B. Lachman, “Interleukin-1 is an astroglial growth factor in the developing brain,” Journal of Neuroscience, vol. 8, no. 2, pp. 709–714, 1988. [24] S. Rakic and N. Zecevic, “Programmed cell death in the developing human telencephalon,” European Journal of Neu- roscience, vol. 12, no. 8, pp. 2721–2734, 2000. [25] W. J. Streit, “Microglia and macrophages in the developing CNS,” NeuroToxicology, vol. 22, no. 5, pp. 619–624, 2001. [26] G. A. Garden and T. Mo¨ller, “Microglia biology in health and disease,” Journal of Neuroimmune Pharmacology, vol. 1, no. 2, pp. 127–137, 2006. [27] M. J. Bell and J. M. Hallenbeck, “Eﬀects of intrauterine inﬂammation on developing rat brain,” Journal of Neuroscience Research, vol. 70, no. 4, pp. 570–579, 2002. [28] E. M. Ullian, S. K. Sapperstein, K. S. Christopherson, and B. A. Barres, “Control of synapse number by glia,” Science, vol. 291, no. 5504, pp. 657–661, 2001. [29] K. S. Christopherson, E. M. Ullian, C. C. A. Stokes et al., “Thrombospondins are astrocyte-secreted proteins that 9 promote CNS synaptogenesis,” Cell, vol. 120, no. 3, pp. 421– 433, 2005. [30] C¸ . Eroglu, N. J. Allen, M. W. Susman et al., “Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis,” Cell, vol. 139, no. 2, pp. 380–392, 2009. [31] O. Garcia, M. Torres, P. Helguera, P. Coskun, and J. Busciglio, “A role for thrombospondin-1 deﬁcits in astrocyte-mediated spine and synaptic pathology in down’s syndrome,” PLoS ONE, vol. 5, no. 12, Article ID e14200, 2010. [32] C. M. Muller and J. Best, “Ocular dominance plasticity in adult cat visual cortex after transplantation of cultured astrocytes,” Nature, vol. 342, no. 6248, pp. 427–430, 1989. [33] L. Bennet and A. Gunn, “The fetal origins of adult mental illness,” in Early Life Origins of Health and Disease (Advances in Experimental Medicine and Biology), M. Wintour-Coghlan and J. Owens, Eds., pp. 204–211, Springer, New York, NY, USA, 2006. [34] D. Rice and S. Barone Jr, “Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models,” Environmental Health Perspectives, vol. 108, supplement 3, pp. 511–533, 2000. [35] M. Hornig, H. Weissenbo¨ck, N. Horscroft, and W. I. Lipkin, “An infection-based model of neurodevelopmental damage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 21, pp. 12102–12107, 1999. [36] K. B. Nelson and R. E. Willoughby, “Infection, inﬂammation and the risk of cerebral palsy,” Current Opinion in Neurology, vol. 13, no. 2, pp. 133–139, 2000. [37] P. Rantakallio, P. Jones, J. Moring, and L. Von Wendt, “Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up,” International Journal of Epidemiology, vol. 26, no. 4, pp. 837–843, 1997. [38] L. Shi, S. H. Fatemi, R. W. Sidwell, and P. H. Patterson, “Maternal inﬂuenza infection causes marked behavioral and pharmacological changes in the oﬀspring,” Journal of Neuro- science, vol. 23, no. 1, pp. 297–302, 2003. [39] N. V. Malkova, C. Z. Yu, E. Y. Hsiao, M. J. Moore, and P. H. Patterson, “Maternal immune activation yields oﬀspring displaying mouse versions of the three core symptoms of autism,” Brain, Behavior, and Immunity, vol. 26, no. 4, pp. 607–616, 2012. [40] S. D. Bilbo and J. M. Schwarz, “Early-life programming of later-life brain and behavior: a critical role for the immune system,” Frontiers in Behavioral Neuroscience, vol. 3, p. 14, 2009. [41] S. D. Bilbo, S. H. Smith, and J. M. Schwarz, “A lifespan approach to neuroinﬂammatory and cognitive disorders: a critical role for glia,” Journal of Neuroimmune Pharmacology, pp. 1–18, 2011. [42] R. B. Elliott, H. E. Wasmuth, N. J. Bibby, A. K. H. Macgibbon, and J. P. Hill, “The eﬀect of beta-casein polymorphism on the stimulation of diabetes in the non-obese diabetic mouse and eﬀect of beta-casomorphin-7 on immune cell activity,” International Dairy Journal, vol. 8, p. 580, 1998. [43] G. A. W. Rook, “Review series on helminths, immune modulation and the hygiene hypothesis: the broader impli- cations of the hygiene hypothesis,” Immunology, vol. 126, no. 1, pp.3–11, 2009. [44] G. Borkow, Q. Leng, Z. Weisman et al., “Chronic immune acti- vation associated with intestinal helminth infections results in impaired signal transduction and anergy,” Journal of Clinical Investigation, vol. 106, no. 8, pp. 1053–1060, 2000.